Why MedTech’s Most Critical Leadership Gap Is Getting Harder to Ignore
Engineering expertise and regulatory accountability almost never sit in the same person. As of February 2, 2026, FDA’s new inspection framework follows risk across the full product lifecycle—and that gap is no longer a background risk. It is a current exposure.
Own Your Device’s Entire Journey: Why Smart Companies Treat Complaints as Strategic Assets
Complaint handling ranked 3rd in FDA warning letter citations in FY2025. With QMSR now in effect, one complaint can trigger MDR evaluation, CAPA, design reviews, risk updates, and multi-stakeholder notifications. Here’s how to stop firefighting and start leading.
The $5 Billion Opportunity: How Requirements Traceability Transforms Medical Device Success
1,059 recalls in 2024. $5B annual cost. The root cause? Broken requirements traceability. Discover the golden thread that connects user needs to design, risk management, and post-market surveillance.